Santen Pharmaceutical Co Ltd (OTCPK:SNPHY)
$ 11.77 -0.82 (-6.51%) Market Cap: 3.79 Bil Enterprise Value: 3.25 Bil PE Ratio: 16.99 PB Ratio: 2.09 GF Score: 79/100

Full Year 2019 Santen Pharmaceutical Co Ltd Earnings Presentation Transcript

May 10, 2019 / 03:30AM GMT
Release Date Price: $15.31 (-1.88%)

May 10, 2019 / 03:30AM GMT
Presentation
May 10, 2019 / 03:30AM GMT

=====================
Corporate Participants
=====================
* Akira Kurokawa
Santen Pharmaceutical Co., Ltd. - Chairman & CEO
* Kazuo Koshiji
Santen Pharmaceutical Co., Ltd. - Senior Corp. Officer of Corporate Administration, CFO and Head of Finance & Administration Division
* Naveed Shams
Santen Pharmaceutical Co., Ltd. - Senior Corporate Officer, Chief Scientific Officer and Head of Global Research & Development
* Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, COO, Head of North America Business & Representative Director

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc, Research Division - MD and Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot